2020 ASH Meeting
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present Expansive New Hematology Data at the 62nd ASH Annual Meeting and Exposition
A total of 22 abstracts have been accepted, predominantly data in several types of blood cancers, including leukemia, lymphoma and myeloma.
Biostatistics - Authorship Policy
Home | Research Accomplishments | Services | Equipment and Software | Authorship Policy
Be In The Know: A five-part series on Lung Cancer Screening, Tobacco Cessation, and Vaping for Healthcare and Public Health Professionals
In the fall of 2020, ScreenNJ and the Rutgers Cancer Institute of New Jersey presented a free five-topic online series on lung cancer screening, tobacco cessation, and vaping for healthcare and public health professionals in New Jersey. Each session was designed to help clinicians, tobacco treatment specialists, and other medical, public health, and social service professionals increase their knowledge of evidence-based practices to improve the health of their clients and patients.
Guo Lung Cancer 2020
Exploring Therapeutic Strategy against Mutations in Non-Small Cell Lung Cancer
‘Jessie’ Yanxiang Guo, PhD, has received a $1.7 million award from the National Institutes of Health to investigate the role of autophagy in the formation of tumors driven by mutations in tumor suppressors.
